Study on CXCR4/SDF-1α axis in lymph node metastasis of cervical squamous cell carcinoma

International Journal of Gynecological Cancer

Volumn 17, Issue 2, 2007, Pages 478-483

  Zhang, J P ^a,b   Lu, W G ^a,c   Ye, F ^c   Chen, H Z ^c   Zhou, C Y ^a   Xie, X ^a,c  

^a ZHEJIANG UNIVERSITY   (China)

^b SUZHOU UNIVERSITY   (China)

^c Women's Reproductive Health Laboratory of Zhejiang Province   (China)

Author keywords

Cervical cancer; Chemokine; CXCR4; Metastasis; SDF 1

Indexed keywords

MONOCLONAL ANTIBODY; STROMAL CELL DERIVED FACTOR 1ALPHA;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CANCER TISSUE; CELL MIGRATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; HELA CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA;

ADULT; AGED; ANTIBODIES, MONOCLONAL; CARCINOMA, SQUAMOUS CELL; CELL MOVEMENT; CELL PROLIFERATION; CHEMOKINES, CXC; FEMALE; HELA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MIDDLE AGED; RECEPTORS, CXCR4; UTERINE CERVICAL NEOPLASMS;

EID: 33947275735     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.00786.x     Document Type: Article

References (31)

1. Homey B, Muller A, Zlotnik A. Chemokines: agents for the immunotherapy of cancer? Nat Rev Immunol 2002;2:175-84.
2. Clore GM, Gronenborn AM. Three-dimensional structures of alpha and beta chemokines. FASEB J 1995;9:57-62.
3. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000;12:121-7.
4. Turner SJ, Domin J, Waterfield MD et al. The CC chemokine monocyte chemotactic peptide-1 activates both the class I p85/p110 phosphatidylinositol 3-kinase and the class II PI3K-C2alpha. J Biol Chem 1998;273: 25987-95.
5. Gonzalo JA, Lloyd CM, Peled A et al. Critical involvement of the chemotactic axis CXCR4/stromal cell-derived factor-1 alpha in the inflammatory component of allergic airway disease. J Immunol 2000;165:499-508.
6. Yoshie O. Role of chemokines in trafficking of lymphocytes and dendritic cells. Int J Hematol 2000;72:399-407.
7. Muller A, Homey B, Soto H et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001;410:50-6.
8. Scotton CJ, Wilson JL, Milliken D et al. Epithelial cancer cell migration: a role for chemokine receptors? Cancer Res 2001;61:4961-5.
9. Taichman RS, Cooper C, Keller ET et al. Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res 2002;62:1832-7.
10. Mohle R, Schittenhelm M, Failenschmid C et al. Functional response of leukaemic blasts to stromal cell-derived factor-1 correlates with preferential expression of the chemokine receptor CXCR4 in acute myelomonocytic and lymphoblastic leukaemia. Br J Haematol 2000;110:563-72.
11. Zhou Y, Larsen PH, Hao C et al. CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J Biol Chem 2002;277:49481-7.
12. Kijima T, Maulik G, Ma PC et al. Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells. Cancer Res 2002;62:6304-11.
13. Hwang JH, Chung HK, Kim DW et al. CXC chemokine receptor 4 expression and function in human anaplastic thyroid cancer cells. J Clin Endocrinol Metab 2003;88:408-16.
14. Murphy PM. Chemokines and the molecular basis of cancer metastasis. N Engl J Med 2001;345:833-5.
15. Balkwill F. The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol 2004;14:171-9.
16. Vicari AP, Caux C. Chemokines in cancer. Cytokine Growth Factor Rev 2002;13:143-54.
17. Strieter RM. Chemokines: not just leukocyte chemoattractants in the promotion of cancer. Nat Immunol 2001;2:285-6.
18. Scotton CJ, Wilson JL, Scott K et al. Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. Cancer Res 2002;62:5930-8.
19. Arai J, Yasukawa M, Yakushijin Y et al. Stromal cells in lymph nodes attract B-lymphoma cells via production of stromal cell-derived factor-1. Eur J Haematol 2000;64:323-32.
20. Koshiba T, Hosotani R, Miyamoto Y et al. Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. Clin Cancer Res 2000;6:3530- 5.
21. Schrader AJ, Lechner O, Templin M et al. CXCR4/CXCL12 expression and signalling in kidney cancer. Br J Cancer 2002;86:1250-6.
22. Eisenhardt A, Frey U, Tack M et al. Expression analysis and potential functional role of the CXCR4 chemokine receptor in bladder cancer. Eur Urol 2005;47:111-7.
23. Parkin DM, Bray F, Ferlay J et al. Global cancer statistics, 2002. CA Cancer J Clin 2005:55:74-108.
24. Balkwill F. Cancer and the chemokine network. Nat Rev Cancer 2004;4:540-50.
25. Murakami T, Maki W, Cardones AR et al. Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. Cancer Res 2002;62:7328-34.
26. Sun YX, Wang J, Shelburne CE et al. Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo. J Cell Biochem 2003;89:462-73.
27. Libura J, Drukala J, Majka M et al. CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion. Blood 2002;100:2597-606.
28. Adams GB, Chabner KT, Foxall RB et al. Heterologous cells cooperate to augment stem cell migration, homing, and engraftment. Blood 2003;101:45-51.
29. Uchida D, Begum NM, Almofti A et al. Possible role of stromal-cell-derived factor-1/CXCR4 signaling on lymph node metastasis of oral squamous cell carcinoma. Exp Cell Res 2003;290:289-302.
30. Barbero S, Bonavia R, Bajetto A et al. Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt. Cancer Res 2003;63:1969-74.
31. Donzella GA, Schols D, Lin SW et al. AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor. Nat Med 1998;4:72-7.